#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4219516	B	Proteolysis targeting chimera activity in human HeLa cells assessed as induction of VCB-mediated delivery of BRD2 for protein degradation by proteasome by measuring drug level causing 50% cellular protein depletion incubated for 24 hrs by Western blotting method	Homo sapiens	5	ALA4219029	cell-based format	Scientific Literature
2.	ALA4219522	B	Proteolysis targeting chimera activity in human HeLa cells assessed as induction of VCB-mediated delivery of BRD2 for protein degradation by proteasome by measuring drug level causing 50% cellular protein depletion incubated for 24 hrs by Western blotting method relative to control	Homo sapiens	7	ALA4219029	cell-based format	Scientific Literature
3.	ALA4219533	B	Proteolysis targeting chimera activity in human HeLa cells assessed as induction of VCB-mediated delivery of BRD2 for protein degradation by proteasome at 30 to 10000 nM incubated for 24 hrs by Western blotting method	Homo sapiens	2	ALA4219029	cell-based format	Scientific Literature
4.	ALA4219537	B	Proteolysis targeting chimera activity in human HeLa cells assessed as induction of VCB-mediated delivery of BRD2 for protein degradation by proteasome at 1 to 10 uM incubated for 24 hrs by Western blotting method	Homo sapiens	2	ALA4219029	cell-based format	Scientific Literature
5.	ALA4219541	B	Proteolysis targeting chimera activity in human HeLa cells assessed as induction of VCB-mediated delivery of BRD2 for protein degradation by proteasome at 1 to 10 uM incubated for 6 hrs by Western blotting method	Homo sapiens	2	ALA4219029	cell-based format	Scientific Literature
6.	ALA4219543	B	Induction of interaction of N-terminal His6-tagged recombinant human VHL (54 to 213 residues)/elongin C (17 to 112 residues)/elongin B (1 to 104 residues) co-expressed in Escherichia coli BL21 (DE3) with recombinant human Brd2 BD1 assessed as VCB/BRD2/compound ternary complex formation by isothermal titration calorimetry-based assay	Homo sapiens	1	ALA4219029	assay format	Scientific Literature
7.	ALA5108368	B	Displacement of (2S,4R)-N-(4-bromobenzyl)-4-hydroxy-1-(3,3,3-trifluoropropanoyl)pyrrolidine-2-carboxamide from BRD2 bromodomain 1/VBC E3 ligase (unknown origin) ternary complex by 19F NMR assay	Homo sapiens	1	ALA5107947	protein format	Scientific Literature
8.	ALA5108369	B	Displacement of (2S,4R)-N-(4-bromobenzyl)-4-hydroxy-1-(3,3,3-trifluoropropanoyl)pyrrolidine-2-carboxamide from BRD2 bromodomain 2/VBC E3 ligase (unknown origin) ternary complex by 19F NMR assay	Homo sapiens	1	ALA5107947	protein format	Scientific Literature
9.	ALA5108374	B	Displacement of (2S,4R)-N-(4-bromobenzyl)-4-hydroxy-1-(3,3,3-trifluoropropanoyl)pyrrolidine-2-carboxamide from BRD2 bromodomain 1/VBC E3 ligase (unknown origin) ternary complex assessed as inhibition constant by 19F NMR assay	Homo sapiens	1	ALA5107947	protein format	Scientific Literature
10.	ALA5108375	B	Displacement of (2S,4R)-N-(4-bromobenzyl)-4-hydroxy-1-(3,3,3-trifluoropropanoyl)pyrrolidine-2-carboxamide from BRD2 bromodomain 2/VBC E3 ligase (unknown origin) ternary complex assessed as inhibition constant by 19F NMR assay	Homo sapiens	1	ALA5107947	protein format	Scientific Literature